Nirsevimab prophylaxis on pediatric intensive care hospitalization for severe acute bronchiolitis: a clinical and economic analysis.

Touati S, Debs A, Morin L, Jule L, Claude C, Tissieres P, PANDORA study group

Open source

DOI
10.1186/s13613-025-01460-0
Published
2025 Apr 26
Container
Annals of intensive care
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13613-025-01460-0,
  title = {Nirsevimab prophylaxis on pediatric intensive care hospitalization for severe acute bronchiolitis: a clinical and economic analysis.},
  author = {Touati S and Debs A and Morin L and Jule L and Claude C and Tissieres P and PANDORA study group},
  year = {2025},
  journal = {Annals of intensive care},
  doi = {10.1186/s13613-025-01460-0},
  url = {https://doi.org/10.1186/s13613-025-01460-0}
}

RIS

TY  - JOUR
TI  - Nirsevimab prophylaxis on pediatric intensive care hospitalization for severe acute bronchiolitis: a clinical and economic analysis.
AU  - Touati S
AU  - Debs A
AU  - Morin L
AU  - Jule L
AU  - Claude C
AU  - Tissieres P
AU  - PANDORA study group
PY  - 2025
JO  - Annals of intensive care
DO  - 10.1186/s13613-025-01460-0
UR  - https://doi.org/10.1186/s13613-025-01460-0
ER  - 

APA

S, T., A, D., L, M., L, J., C, C., P, T., & group, P. S. (2025). Nirsevimab prophylaxis on pediatric intensive care hospitalization for severe acute bronchiolitis: a clinical and economic analysis.. Annals of intensive care. https://doi.org/10.1186/s13613-025-01460-0

Source records